China Shineway Pharmaceutical Group Limited (C1S) — Cash Flow Reinvestment Rate
China Shineway Pharmaceutical Group Limited (C1S) has a Cash Flow Reinvestment Rate of 0.17x as of June 2023, reinvesting €26.64 Million (capex €24.57 Million plus investments €2.06 Million) from operating cash flow of €160.69 Million. See C1S cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
China Shineway Pharmaceutical Group Limited Cash Flow Reinvestment Rate (2013–2025)
Historical reinvestment intensity for China Shineway Pharmaceutical Group Limited across 13 annual periods. For the full cash flow conversion analysis, see C1S cash flow metrics.
Annual Cash Flow Reinvestment Rate for China Shineway Pharmaceutical Group Limited (2013–2025)
Year-by-year capital reinvestment analysis for China Shineway Pharmaceutical Group Limited. See China Shineway Pharmaceutical Group Limi (C1S) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.30x | €348.24 Million | €1.17 Billion | €197.91 Million | ▼ -37.4% |
| 2024 | 0.48x | €457.50 Million | €963.13 Million | €140.11 Million | ▲ +186.1% |
| 2023 | 0.17x | €154.86 Million | €932.63 Million | €144.32 Million | ▲ +35.4% |
| 2022 | 0.12x | €136.13 Million | €1.11 Billion | €129.46 Million | ▼ -15.7% |
| 2021 | 0.15x | €102.37 Million | €703.15 Million | €93.63 Million | ▼ -15.4% |
| 2020 | 0.17x | €109.93 Million | €638.57 Million | €66.03 Million | ▼ -40.4% |
| 2019 | 0.29x | €106.33 Million | €368.00 Million | €88.40 Million | ▲ +13.1% |
| 2018 | 0.26x | €136.07 Million | €532.59 Million | €127.34 Million | ▲ +24.7% |
| 2017 | 0.20x | €100.56 Million | €490.65 Million | €91.83 Million | ▼ -19.4% |
| 2016 | 0.25x | €186.50 Million | €733.53 Million | €106.79 Million | ▲ +24.8% |
| 2015 | 0.20x | €151.71 Million | €744.71 Million | €106.56 Million | ▼ -12.1% |
| 2014 | 0.23x | €179.20 Million | €773.16 Million | €104.18 Million | ▼ -60.9% |
| 2013 | 0.59x | €308.46 Million | €519.89 Million | €261.89 Million | — |